Peter Thompson, M.D.

Peter is a board-certified internist and oncologist and Affiliate Professor of Neurosurgery at the University of Washington. He currently serves on the Board of ProLynx, Inc., and has over 30 years of industry experience, serving leadership roles with Becton-Dickinson, Chiron, Trubion Pharmaceuticals, Corvus Pharmaceuticals, Cleave Biosciences, Silverback Therapeutics, Edgewise Therapeutics, and Terremoto BioSciences. He also served on the staff at the National Cancer Institute and is an Ernst & Young Entrepreneur of the Year awardee. Peter earned his M.D. from Brown University Medical School.